Evaluation of plasma activity level of anticoagulant proteins in patients with acute lymphoblastic leukemia in Shafa hospital Ahwaz 2010

European Review for Medical and Pharmacological Sciences

Volumn 16, Issue 8, 2012, Pages 1045-1051

  Jalali, M T ^a   Khosravi, Mahmood ^a   Keikhaei, B ^a   Dehuori, F ^a   Latifi, M ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acute lymphoblastic leukemia; Antithrombin; Protein C; Protein S; Thrombosis

Indexed keywords

ACTIVATED PROTEIN C RECEPTOR; ANTICOAGULANT PROTEIN; ANTITHROMBIN; D DIMER; PROTEIN C; PROTEIN S; UNCLASSIFIED DRUG; ANTICOAGULANT AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BLOOD CLOTTING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MALE; PRESCHOOL CHILD; PROTEIN ANALYSIS; SCHOOL CHILD; BLOOD; THROMBOCYTE COUNT;

ADOLESCENT; ANTICOAGULANTS; ANTITHROMBINS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; PLATELET COUNT; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTEIN C; PROTEIN S;

EID: 84865810743     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. PUI CH, RELLING MV, DOWNING Jr. Acute lymphoblastic leukemia. N Engl J Med 2004; 350: 1535-1548.
2. PUI CH, ROBISON LL, LOOK AT. Acute lymphoblastic leukemia. Lancet 2008; 371:1030-1043.
3. FALANGA A, MARCHETTI M. Venous thromboembolism in the hematological malignancies. J Clin Oncol 2009; 27: 4848-4857.
4. CARUSO V, IACOVIELLO L, DI CASTELNUOVO A, STORTI S, MARIANI G, DE GAETANO G, DONATI MB. Thrombotic complications in childhood acute lymphoblastic leukemia:A meta-analysis of 17 prospective studies comprising 1752 pediatric patients. Blood 2006; 108: 2216-2222.
5. SEEGERS WH, NOVOA E, HENRY RL, HASSOUNA HI. Relationship of "new" vitamin K-dependent protein C and "old" autoprothrombin II-A. Thromb Res 1976; 8: 543-552.
6. ROSENBERG RD, ROSENBERG JS. Natural anticoagulant mechanisms. J Clin Invest 1984; 74: 1-21.
7. CLOUSE LH, COMP PC. The regulation of hemostasis: The protein C system. N Engl J Med 1986; 314: 1298-1312.
8. GETTINS PG. Serpin structure, mechanism, and function. Chem Rev 2002; 102: 4751-4760.
9. RAU JC, BEAULIEU LM, HUNTINGTON JA, CHURCH FC. Serpins in thrombosis, hemostasis and fibrinolysis. J Thromb Haemost 2007; 5: 102-112.
10. HUNTINGTON JA. Mechanisms of glycosaminoglycan activation of the serpins in hemostasis. J Thromb Haemost 2003; 1: 1535-1547.
11. DIXIT A, KANNAN M, MAHAPATRA M, CHOUDHRY VP, SAXENA R. Roles of protein C, protein S, and antithrombin III in acute leukemia. Am J Hematol 2006; 81: 171-174.
12. SUN X, EVATT B, GRIFFIN JH. Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia. Blood 1994; 83: 3120-3128.
13. AY C, VORMITTAG R, DUNKLER D. D-dimer and prothrombin fragment 1.2 predict venous thromboembolism in patients with cancer: Results from the Vienna Cancer and Thrombosis Study. J Clin Oncol 2009; 27: 4124-4129.
14. BONEU B, BES G, PELZER H, SIE P, BOCCALON H. DDimers, thrombin antithrombin III complexes and prothrombin fragments 1.2: Diagnostic value in clinically suspected deep vein thrombosis. Thromb Haemost 1991; 65: 28-31.
15. TROY K, ESSEX D, RAND J, LEMA M, CUTTNER J. Protein C and S levels in acute leukemia. Am J Hematol 1991; 37: 160-175.
16. MITCHELL LG, ANDREW M, HANNA K, ABSHIRE T, ANDERSON R, CHERRICK I, DESAI S, MAHONEY D, MCCUSTER P, WU J, DAHL G, CHAIT P, DE VEBER G, LEE KJ, MIKULIS D, GINSBERG J, WAY C; PROPHYLACTIC ANTITHROMBIN REPLACEMENT IN KIDS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH ASPARAGINASE GROUP (PARKAA). A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase. Results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastc Leukemia Treated with Asparaginase (PARKAA) study. Cancer 2003; 97: 508-516.
17. PAYNE JH, VORA AJ. Thrombosis and acute lymphoblastic leukaemia. Br J Haematol 2007; 138: 430-445.
18. KAHN ML, NAKANISHI-MATSUI M, SHAPIRO MJ, ISHIHARA H, COUGHLIN SR. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest 1999; 103: 879-889.
19. ESMON CT. The interactions between inflammation and coagulation. Br J Haematol 2005; 131: 417-430.
20. ESMON CT. The impact of the inflammatory response on coagulation. Thromb Res 2004; 114: 321-327.
21. HUNAULT-BERGER M, CHEVALLIER P, DELAIN M. Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: The CAPELAL study. Haematologica 2008; 93: 1488-1494.
22. APPEL IM, HOP WC, VAN KESSEL-BAKVIS C. L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia. Thromb Haemost 2008; 100: 330-337.
23. ALESSIO MG, FALANGA A, CONSONNI R. Cancer procoagulant in acute lymphoblastic leukemia. Eur J Haematol 1990; 45: 78-81.
24. FALANGA A, IACOVIELLO L, EVANGELISTA V. Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-transretinoic acid. Blood 1995; 86: 107-1081.
25. ZIEGLER S, SPERR WR, KNOBL P, LEHR S, WELTERMANN A, JAGER U,VALENT P, LECHNER K. Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosis. Thromb Res 2005; 115: 59-64.
26. LEE AY. Cancer and thromboembolic disease: Pathogenic mechanisms. Cancer Treat Rev 2002; 28: 137-140.
27. GRALNICK HR, MARCHESI S, GIKELBER H. Intravascular coagulation in acute leukemia: Clinical and subclinical abnormalities. Blood 1972; 40: 709-718.